Unknown

Dataset Information

0

Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

ABSTRACT:

SUBMITTER: James MH 

PROVIDER: S-EPMC7265392 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

James Morgan H MH   Fragale Jennifer E JE   Aurora R Nisha RN   Cooperman Nina A NA   Langleben Daniel D DD   Aston-Jones Gary G  

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20200127 5

Similar Datasets

Unknown Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea.
| S-EPMC4702197 | biostudies-literature
Unknown Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine.
| S-EPMC5854790 | biostudies-literature
Unknown Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users.
| S-EPMC9257054 | biostudies-literature
Unknown Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users.
| S-EPMC9257063 | biostudies-literature
Unknown Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine.
| S-EPMC5645207 | biostudies-literature
Unknown Effects of the dual orexin receptor antagonist DORA-22 on sleep in 5XFAD mice.
| S-EPMC6396100 | biostudies-literature
Unknown Preliminary examination of orexin receptor antagonism with suvorexant in individuals with Methamphetamine use disorder: a case series study.
| S-EPMC12207614 | biostudies-literature
Unknown Machine-learning repurposing of DrugBank compounds for opioid use disorder.
| S-EPMC10202846 | biostudies-literature
Unknown Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit.
| S-EPMC7371384 | biostudies-literature
Unknown Sleep Deficiency and Opioid Use Disorder: Trajectory, Mechanisms, and Interventions.
| S-EPMC10018646 | biostudies-literature